CCL-18 AS A BIOMARKER OF INTERSTITIAL LUNG DISEASE (ILD) AND PROGRESSIVE FIBROSING ILD IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

被引：0
|
作者：
Zanatta, E. [1 ]
Depascale, R. [1 ]
Gamba, A. [1 ]
Tonello, M. [1 ]
Martini, A. [2 ]
Gatto, M. [1 ]
Doria, A. [1 ]
Iaccarino, L. [1 ]
机构：
[1] Univ Hosp Padova, Dept Med, Rheumatol Unit, Padua, Italy
[2] Univ Hosp Padova, Dept Med, Unit Internal Med & Hepatol, Padua, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Biomarkers; Myositis; Lungs;
D O I：
10.1136/annrheumdis-2023-eular.6184
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1217
引用
收藏
页码：943 / 944
页数：2
相关论文
共 50 条
  • [31] A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study
    Nasser, Mouhamad
    Larrieu, Sophie
    Si-Mohamed, Salim
    Ahmad, Kais
    Boussel, Loic
    Brevet, Marie
    Chalabreysse, Lara
    Fabre, Celine
    Marque, Sebastien
    Revel, Didier
    Thivolet-Bejui, Francoise
    Traclet, Julie
    Zeghmar, Sabrina
    Maucort-Boulch, Delphine
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [32] Impact of ILD-specific therapies on perioperative course in patients with progressive fibrosing ILD undergoing lung transplantation
    Munker, D.
    Arnold, P.
    Leuschner, G.
    Sisic, A.
    Barton, J.
    Weig, T.
    Michel, S.
    Kauke, T.
    Meiser, B.
    Milger-Kneidinger, K.
    Behr, J.
    Kneidinger, N.
    Veit, T.
    PNEUMOLOGIE, 2023, 77 : S20 - S21
  • [33] Racial Disparities In Survival Of Interstitial Lung Disease (ild) Patients Independent Of Ild Phenotype
    Hawley, J. E.
    Kawut, S. M.
    Peterson, E. R.
    Philip, N.
    Arcasoy, S. M.
    Lederer, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [34] EFFECTS OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS (RA-ILD) IN THE INBUILD TRIAL
    Kelly, C.
    Matteson, E.
    Aringer, M.
    Burmester, G. R.
    Mueller, H.
    Moros, L.
    Rohr, K.
    Kolb, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 69 - 69
  • [35] Effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in the INBUILD trial
    Koschel, D.
    Kelly, C.
    Matteson, E.
    Aringer, M.
    Burmester, G.
    Mueller, H.
    Moros, L.
    Rohr, B. K.
    Kolb, M.
    PNEUMOLOGIE, 2022, 76 : S21 - S21
  • [36] Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
    De Sadeleer, Laurens J.
    Goos, Tinne
    Yserbyt, Jonas
    Wuyts, Wim A.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 10
  • [37] Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies
    Shao, Chenyi
    Xia, Nana
    Zhen, Yan
    Zhang, Xueliang
    Yan, Ninghui
    Guo, Qiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] COST OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (PF-ILD) IN SPAIN: A DELPHI APPROACH
    Ramon, A.
    Valenzuela, C.
    Aburto, M.
    Narvaez, J.
    Simeon, C. P.
    Serra, M.
    Palomino, R.
    VALUE IN HEALTH, 2022, 25 (12) : S158 - S158
  • [39] Urokinase Plasminogen Activator (upa) Is Increased In Interstitial Lung Disease (ild): A Potential Fibrogenic Mediator And Biomarker In Ild
    Schuliga, M.
    Jaffar, J.
    Berhan, A.
    Langenbach, S.
    Harris, T.
    Westall, G.
    Stewart, A. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [40] Characteristics and Treatment of Patients with fibrosing interstitial Lung Disease in clinical Practice: INSIGHTS-ILD Registry
    Behr, J.
    Kreuter, M.
    Prasse, A.
    Gunther, A.
    Bonella, F.
    Pittrow, D.
    Neurohr, C.
    Waelscher, J.
    Grunewaldt, A.
    Ewert, R.
    Markart, P.
    Gesierich, W.
    Biller, H.
    Westhoff, M.
    Eisenmann, S.
    Andreica, I
    Wilkens, H.
    Wirtz, H.
    Neff, U.
    Budweiser, S.
    Hagmeyer, L.
    Thabaret, K.
    Meyer, F.
    Schwaiblmair, M.
    Drobbe, L.
    Frankenberger, M.
    Claussen, M.
    Schramm, P.
    Klotsche, J.
    Veit, T.
    Kreutz, C.
    Kirschner, J.
    Held, M.
    Kabitz, H.
    Pausch, C.
    Walterspacher, S.
    Grohe, C.
    Grund, D.
    Glaeser, S.
    Skowasch, D.
    Reichenberger, F.
    Haberl, S.
    Seese, B.
    Polke, M.
    Von Wulffen, W.
    Krauss, E.
    Weber, M.
    Koschel, D.
    PNEUMOLOGIE, 2024, 78 : S75 - S76
12345